BioUK Life Science Registry

Member list of BioUK

Below you find a list of all members of BioUK in alphabetical order.
Results 301 - 320 out of 523 displayed
Myeloma UK

22 Logie Mill
Beaverbank Business Park
Edinburgh, EH7 4HG
United Kingdom

Main sector:

Public / Non-Profit Organizations / Medical Facilities

Subsector:

Other, Research facility

Description:

Myeloma UK is the only charity in the United Kingdom dedicated exclusively to myeloma, an incurable but treatable blood cancer that develops in the bone marrow's plasma cells. The organisation operates entirely on voluntary donations and fundraising to support patients, advance clinical research, and accelerate access to newer treatments.

Myomaker Bio Ltd

Holywell Way
Luinc Holywell Building, Leicestershire
Loughborough, LE11 3UZ
United Kingdom

Main sector:

Biotechnology - R&D Services

Subsector:

Analytical services, CRO (Contract Research Organization), Screening

Description:

Myomaker Bio Ltd is the biotechnology company which focuses on drug discovery and development stage related to muscle biology. The company provides contract resesrch services on screening, and partnership development of advanced organ models. Muscle morphology, muscle function analysis are performed using the human-relevant 3D muscle models and precision assays.

Mytos

80 Wood Lane
Translation & Innovation Hub, Imperial College White City Campus
London, W12 0BZ
United Kingdom

Main sector:

Supplier & Engineering

Subsector:

Instrumentation, Laboratory equipment

Description:

Mytos has developed an automated platform that handles the manual and complex tasks associated with mammalian cell culture. The company's iDEM™ platform, is an automated manufacturing system designed for the production of mammalian cells. This technology is utilized by biotechnology and pharmaceutical companies to standardize the growth and differentiation of human cells for use in clinical trials and therapeutic applications.

NanOptima Ltd

Alderley Park
Alderley Edge
Cheshire, SK10 7TG
United Kingdom

Main sector:

Biotechnology - Therapeutics and Diagnostics

Subsector:

Antibodies, Drug delivery, Peptides, Proteins, Natural Compounds

Indications:

Diseases of the eye / ophthalmology

Products:
In development: 2
Description:

NanOptima’s propriety NAAmatrix™ is engineered to address one of ophthalmology’s biggest unmet needs: injection durability and adherence crisis. Anti-VEGF drugs work: clinical trials deliver 8–10 ETDRS letter gains. The real world delivers 1.5–3.5. The gap is not efficacy, it is durability. Approximately 50% of patients discontinue treatment by year two, driving irreversible, preventable vision loss at scale. Patients and healthcare systems cannot sustain 1-3 monthly injections.

NAAmatrix™ is a bioresorbable natural amino-acid matrix that extends proven anti-VEGF biologics, peptides, and small molecules to >6 months from a single standard 30G intravitreal injection. No device. No surgery. No curing. No drug modification. No workflow change (frictionless clinical practice). Clean 28-day in vivo tolerability confirmed. Six-month in vitro sustained release confirmed. Aflibercept showing > 6 months and TKI data now showing >8 months. GB priority patent filed.

NanoSyrinx Ltd.

Sir William Lyons Road
The Venture Centre, University of Warwick Science Park
Coventry, CV47EZ
United Kingdom

Main sector:

Biotechnology - Therapeutics and Diagnostics

Subsector:

Drug delivery, Peptides, Proteins

Description:

NanoSyrinx is a discovery stage synthetic biology company developing a novel “nanosyringe” system by delivering therapeutic proteins and peptides direct to the cytosol in a targeted manner. NanoSyrinx’s proprietary platform utilises a core suite of genes, encoding the syringe ‘chassis’, the biological payloads and cell targeting domains which, when expressed, self-assemble in a single step to produce fully formed Nanosyringes.

Nanovery Ltd.

Draymans Way
The Biosphere
Newcastle Upon Tyne, NE4 5BX
United Kingdom

Main sector:

Biotechnology - R&D Services

Subsector:

Analytical services, Diagnostic instrumentation, Diagnostic services

Indications:

Infectious and parasitic diseases / infectiology / parasitology, Neoplasms / cancer / oncology, Digestive system / gastroenterology, Genitourinary system / Urology, Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified, Injury, poisoning and certain other consequences of external causes / toxicology

Employees:
At this location: 10
Worldwide: 10
Description:

Nanovery Ltd. is developing a point-of care diagnostic solution, offering an innovative method of detecting and monitoring the most devastating diseases. The solution makes use of pioneering DNA nanotechnology and DNA computing techniques to create nanosensors that recognise trace amount of disease biomarkers in patient samples (blood, urine, etc). When the DNA/RNA biomarker is detected, the sensor releases a fluorescent signal, thus giving a rapid response to a clinician, indicating the need for further investigation.

National Institute for Health and Care Research

Hertfordshire,
United Kingdom

Main sector:

Public / Non-Profit Organizations / Medical Facilities

Subsector:

Governmental organization, Research facility

Description:

The National Institute for Health and Care Research (NIHR) serves as the primary government agency for health and social care research in the United Kingdom, funded through the Department of Health and Social Care. Its objective is to maintain a comprehensive research system that integrates the National Health Service (NHS) with specialized infrastructure, world-class facilities, and professional training for researchers. By focusing on the specific needs of patients, service users, and the public, the organization aims to improve national health outcomes and contribute to the UK’s economic wealth through partnerships with the life sciences industry.

Nekton Foundation

Begbroke Science & Innovation, Oxfordshire
Oxford, OX5 1PF
United Kingdom

Main sector:

Public / Non-Profit Organizations / Medical Facilities

Subsector:

Foundation

Description:

Nekton Foundation is a charitable organization focused on advancing scientific exploration and conservation of the global ocean. The foundation organizes large-scale ocean expeditions that map unexplored marine ecosystems, discover new species, and collect scientific data for conservation and policy development. Nekton Foundation's work emphasizes open science, with research conducted jointly with host nations and international scientific institutions. Nekton collaborates with governments, universities, research institutes, philanthropic organizations, and industry partners to deliver multidisciplinary ocean exploration programs. The organization also promotes public awareness of ocean science through documentaries, educational initiatives, and cultural engagement. Scientific findings generated by Nekton are intended to support marine protected areas, sustainable ocean management, and global biodiversity commitments.

neo-fossil LTD

Midland Rd
Science Creates - Old Market
Bristol, BS2 0NS
United Kingdom

Main sector:

Biotechnology - Other

Subsector:

Environmental

Description:

neo-fossil LTD is aiming to develop engineered cells to store atmospheric CO2 for centuries.

NeoVac Ltd.

127 Olympic Avenue
Unit 1&2 West
Milton Park, OX14 4SA
United Kingdom

Main sector:

Biotechnology - Therapeutics and Diagnostics

Subsector:

Drug delivery, Nucleic acid drugs, Vaccines

Indications:

Infectious and parasitic diseases / infectiology / parasitology, Neoplasms / cancer / oncology, Respiratory / pulmonology, Digestive system / gastroenterology

Employees:
At this location: 27
Worldwide: 27
Description:

NeoVac is developing a LNP platform to deliver improved mRNA vaccines and treatments for various diseases.

The company's proprietary next generation lipid nanoparticles enable better RNA vaccines. The aim is to make RNA vaccines more transportable, with broader capabilities and less side effects.

Netherlands Foreign Investment Agency

38 Hyde Park Gate
London, SW7 5DP
United Kingdom

Main sector:

Professional Services and Consulting

Subsector:

Other

Description:

NFIA helps and advises foreign companies in all phases of establishing, rolling out and/or expanding their international activities in the Netherlands. NFIA’s free and confidential services include organizing fact-finding missions; arranging meetings with relevant partners; and providing personalized guidance and counsel on tax, government, labor and permit procedures, location options and business solutions.

Neurone Ltd

Chilvester Hill, Chilvester lodge
Calne, SN11 0LP
United Kingdom

Main sector:

Pharma (fully integrated)

Subsector:

Other

Indications:

Infectious and parasitic diseases / infectiology / parasitology

Description:

Neurone Ltd is a UK-based pharmaceutical development SME specializing in complex botanical medicines and cannabinoids. The company uses complex botanical extracts, obtained from botanical raw material grown in licensed growing facility, to create novel extract based pharmaceutical products. Neurone develop IP protected, complex botanical medicines, executing the clinical trials required to secure FDA and other international regulatory approvals in order to enable prescribing and reimbursement needed to achieve broad patient access.

New England Biolabs (UK) Ltd

Wilbury Way
75-77 Knowl Piece
Hitchin, SG4 0TY
United Kingdom

Main sector:

Supplier & Engineering

Subsector:

Distributors, Laboratory consumables and reagents

Description:

New England Biolabs, Inc. is active in the production and supply of reagents for the life science industry. The UK subsidiary office of New England Biolabs provides sales and technical support to their customers in the UK.

NewalR&D Limited

66 Regent's Park Road
London, NW1 7SX
United Kingdom

Main sector:

Biotechnology - Therapeutics and Diagnostics

Subsector:

Anti-infectives, Peptides, Immunotherapy

Indications:

Infectious and parasitic diseases / infectiology / parasitology, Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology

Description:

Newal R&D Ltd is a immune-pharmaceutical company developing ezrin-peptide for human health, based on patent protected and innovative platform technology.
Newal R&D is currently developing generation-3 and generation-4 synthetic ezrin peptide products, initially as a one-stop therapy for the treatment of all sexually transmitted infections. NewalR&D is also developing ezrin peptides for the treatment of age-related chronic inflammatory diseases, for the treatment of long COVID and COVID-vaccine injury.

Newcleic Ltd

1 Thornbury Gardens
Borehamwood, WD6 1RB
United Kingdom

Main sector:

Biotechnology - R&D Services

Subsector:

Other

Indications:

Endocrine, nutritional and metabolic diseases / endocrinology, Diseases of the nervous system / neurology

Description:

Newcleic Ltd is a UK-based biotechnology company focused on developing next-generation DNA manufacturing technologies. The company specializes in advanced long DNA production platforms combined with artificial intelligence and machine learning approaches to support applications in plant breeding, biotechnology, therapeutics, and agricultural innovation. Newcleic aims to make DNA design and production faster, more accurate, and more accessible, enabling the development of improved crop varieties and other biological solutions.

Newrotex Ltd

1 Robert Robinson Avenue
Magdalen Centre
Oxford, OX4 4GA
United Kingdom

Main sector:

Medical Technology

Subsector:

Biomaterials, Regenerative Medicine, Single use devices

Indications:

Diseases of the nervous system / neurology, Musculoskeletal system and connective tissue / Orthopedics

Products:
In development: 1
Description:

Newrotex is developing nerve stents produced from medical grade silk to treat peripheral nerve injury (PNI). The company's 'off-the-shelf' device allows immediate treatment for patients who have suffered injury through trauma or cancer surgery, without any of the associated risks of the current gold-standard treatment of autografts.

Nikalyte Ltd

77 Heyford Park
Cherwell Innovation Centre, Upper Heyford
Bicester, OX25 5HD
United Kingdom

Main sector:

Biotechnology - R&D Services

Subsector:

Bioelectronics, Drug delivery

Description:

Nikalyte Ltd is a leading supplier of nanoparticle coating equipment and services for R&D and commercial use in a wide variety of application areas including cell binding, cell separation, drug delivery, catalysis, metamaterials, nano-photonics, electrochemistry and battery technology.

Nikon UK

1 The Crescent
Surbiton, Surrey
London, KT6 4BN
United Kingdom

Main sector:

Supplier & Engineering

Subsector:

Distributors, Electronics, Laboratory equipment

Description:

Nikon UK manufactures electronic products. The company offers products such as digital cameras, film cameras, lenses, speed lights, film scanners, semiconductors, LCD panels, and other products. Nikon operates worldwide. Nikon Imaging Centers and Nikon Centers of Excellence are cutting-edge facilities formed through partnerships with leading research institutes.

Nordic Mentor Network for Entrepreneurship (NOME)

Fruebjergvej 3
Symbion Science Park
Copenhagen, 2100
Denmark

Main sector:

Professional Services and Consulting

Subsector:

Business development, Deal arranger, Information provider, Technology transfer

Description:

Nordic Mentor Network for Entrepreneurship is a Nordic mentoring program for promising life science projects and start-ups. NOME matches Nordic projects and startups with volunteer professionals to help them reach their goals and technology milestones.

Novotech

66 Goulburn Street
level 19
Sydney, 2000
Australia

Main sector:

Biotechnology - R&D Services

Subsector:

CRO (Contract Research Organization)

Employees:
At this location: 200
Description:

Novotech is a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase. Novotech provides clients an accelerated path to bring life-changing therapies to market by providing access to key clinical trial destinations and diverse patient populations.

Through its client-centric service model, Novotech seamlessly integrates people, processes, and technologies to deliver customized solutions that accelerate the path to market for life-changing therapies. Together with clients, Novotech transforms scientific advancements into therapies that improve global health outcomes, embodying a mission of driving innovation and delivering impactful results.

Results 301 - 320 out of 523 displayed